Mejia, Miecel C.
HRN: 23-78-74 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2023
CEFUROXIME 1.5GM (VIAL)
09/29/2023
09/30/2023
IV
1.5g
Q8
S/P NSVD To Stillborn; CAP
Checking Final Appropriateness
Indication: Empiric Type of Infection: PneumoniaReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes